Monday, December 23, 2024
HomeTagsPhase 2/3 Study

Phase 2/3 Study

RedHill Biopharma’s Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study in Severely Ill Hospitalized COVID-19 Patients

RedHill Biopharma Ltd.("RedHill" or the "Company"), a specialty biopharmaceutical company, announced new data from a prespecified analysis of all oral opaganib's Phase 2/3 study...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics